Tenofovir Disoproxil Fumarate Tablet
Product Images NDC 64380-714

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Tenofovir Disoproxil Fumarate (NDC 64380-714). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97ace9ef C343 42bb 8953 E6449244f265 01

FDA Label Image

97ace9ef C343 42bb 8953 E6449244f265 02

97ace9ef C343 42bb 8953 E6449244f265 02
Each film-coated tablet contains 300 mg of Tenofovir Disoproxil Fumarate which is equivalent to 245 mg of Tenofovir Disoproxil. The tablets are manufactured by Strides Pharma Science Ltd. and distributed by Strides Pharma Inc. The usual dosage and administration should be followed as per the package insert. The tablets should be stored at a temperature of 25°C (77°F) with excursions permitted to 15-30°C (59-86°F) as per USP Controlled Room Temperature. Batch details are not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.